Advertising & Promotion for Medical Products Conference

October 17–18, 2024   In-Person & Virtual Event

Agenda

Subject to Change       
All Times Are Eastern Standard Time

To view the session description, please click on the session title. 

Thursday, October 17

Christine M. Simmon, President & CEO, FDLI
Dale Cooke, President, PhillyCooke Consulting, and Co-Chair, Advertising and Promotion for Medical Products Conference Planning Committee

Elizabeth Jungman, Chief of Staff, Office of the Commissioner, FDA
Arun G. Rao, Deputy Assistant Attorney General, Consumer Protection Branch, Civil Division, DOJ
Annie Ugurlayan, Assistant Director, National Advertising Division, BBB National Programs
Serena Viswanathan, Associate Director, Division of Advertising Practices, FTC
Moderated by Christine M. Simmon, President & CEO, FDLI

FDA panelists will provide updates on regulatory advancements and address frequently asked questions about medical product promotion. 

Catherine B. Gray, Office Director, Office of Prescription Drug Promotion, CDER, FDA

11:10–11:20 AM | Refreshment Break

12:30–1:30 PM  | Lunch Break

1:45–2:45 PM | Concurrent Breakout Sessions

Abraham Gitterman, Senior Associate, Arnold and Porter
Andrew Hasty, Attorney, FTC

2:45–3:00 PM | Refreshment Break

Moderated by Dale Cooke, President, PhillyCooke Consulting, and Co-Chair, Advertising and Promotion for Medical Products Conference Planning Committee

Hannah Bornstein, Partner, Nixon Peabody LLP

5:00–6:00 PM | Reception (In-Person Only)

Friday, October 18

Lauren-Caroline Tadros Potter, Assistant Director, FDLI
Jae Kim, Partner, DLA Piper LLP (US), and Co-Chair, Advertising and Promotion for Medical Products Conference Planning Committee

10:30–10:45 AM | Refreshment Break

Moderated by Anisa Mohanty, Of Counsel, DLA Piper LLP (US)

12:00–1:00 PM | Keynote Lunch Break (In-Person Only)

1:15–2:15 PM | Concurrent Breakout Sessions

Mark Gardner, Managing Partner, Gardner Law, PLLC
Eva A. Temkin, Partner, Arnold & Porter LLP

Moderated by Jae Kim, Partner, DLA Piper LLP (US), and Co-Chair, Advertising and Promotion for Medical Products Conference Planning Committee

3:30 PM  | Closing Remarks and Conference Adjournment